Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;33(10):1244-1252.
doi: 10.1111/tri.13680. Epub 2020 Aug 13.

Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry

Wojciech G Polak  1 , Constantino Fondevila  2 , Vincent Karam  3 , Rene Adam  4 , Ulrich Baumann  5   6 , Giacomo Germani  7 , Silvio Nadalin  8 , Pavel Taimr  9 , Christian Toso  10 , Roberto I Troisi  11 , Krzysztof Zieniewicz  12 , Luca S Belli  13 , Christophe Duvoux  14
Affiliations

Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry

Wojciech G Polak et al. Transpl Int. 2020 Oct.

Abstract

There are scarce data on the impact of COVID-19 pandemic on liver transplantation (LT) in Europe. The aim of this study was to obtain a preliminary data on incidence, management, and outcome of COVID-19 in liver transplant recipients and candidates in Europe. An Internet-based survey was sent to the centers affiliated with European Liver Transplant Registry (ELTR). One hundred nine out of 149 (73%) of ELTR centers located in 28 European countries (93%) responded. Ninety-four (86%) of the centers tested all donors, and 75 (69%) centers tested all LT recipients for SARS-CoV-2. Seventy-three (67%) centers selected recipients for LT in the COVID-19 pandemic, whereas 33% did not. Eighty-eight centers reported COVID-19 infection in 57 LT candidates and in 272 LT recipients. Overall crude incidence of COVID-19 among LT candidates and recipients was estimated 1.05% (range 0.5-20%) and 0.34% (range 0.1-4.8%), respectively, and it was significantly higher among candidates (P < 0.001). Crude rate of death was 18% (10/57) among candidates and 15% (36/244) among recipients. This first large-scale European snapshot study clearly shows that both LT candidates and recipients are at a high risk for COVID-19. These results plead for an early and pro-active screening of COVID-19 symptoms in these populations.

Keywords: COVID-19; SARS-CoV-2; liver recipient; liver transplantation; mortality; survey.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflicts of interest.

Figures

Figure 1
Figure 1
Outline of the study.
Figure 2
Figure 2
Management of liver donors in European center during COVID‐19 pandemic. (a) Donor testing with nasopharyngeal swab PCR for SARS‐CoV‐2. (b) Liver transplantation from SARS‐CoV‐2 positive donors. (c) Recipient selection for liver grafts from SARS‐CoV‐2 positive donors. (d) Living liver donors testing for SARS‐CoV‐2. E. Delay time in live liver donation in SARS‐CoV‐2 positive donors.
Figure 3
Figure 3
Management of liver recipients in European center during COVID‐19 pandemic. (a) Potential recipient testing with nasopharyngeal swab PCR for SARS‐CoV‐2. (b) Consequences of SARS‐CoV‐2 positivity in the potential liver recipient. (c) Consequences of unknown SARS‐CoV‐19 status in the potential liver recipient. (d) Selection of liver recipient for transplantation in COVID‐19 pandemic. (e) Management of SARS‐CoV‐2 positive liver recipients.
Figure 4
Figure 4
Number of SARS‐CoV‐2 positive liver transplant recipient and candidates.
Figure 5
Figure 5
Distribution of SARS‐CoV‐2 positive liver transplant candidates and recipient and in Europe.
Figure 6
Figure 6
Incidence of SARS‐CoV‐2 in liver transplant patients compared to the general population.
Figure 7
Figure 7
Intensive care admission among SARS‐CoV‐2 positive liver transplant patients.
Figure 8
Figure 8
Incidence of mortality among SARS‐CoV‐2 positive liver transplant patients compared to the general population.
See this image and copyright information in PMC

Comment in

References

    1. Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID‐19 in Europe: a case series. Lancet Infect Dis 2020; 20: 697. - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054. - PMC - PubMed
    1. http://www.euro.who.int/en/health‐topics/health‐emergencies/coronavirus‐....
    1. Akalin E, Azzi Y, Bartash R, et al. Covid‐19 and kidney transplantation. N Engl J Med 2020; 382: 2475. - PMC - PubMed
    1. Fernández‐Ruiz M, Andrés A, Loinaz C, et al. COVID‐19 in solid organ transplant recipients: a single‐center case series from Spain. Am J Transplant 2020; 20: 1849. - PMC - PubMed

MeSH terms